This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated.Cannabidiol, the non-psychoactive ingredient in hemp and marijuana, could treat opioid addiction, a new study says. Given to patients with heroin addiction, cannabidiol, also known as CBD, reduced their cravings for the illicit drug as well as their levels of anxiety. “The intense craving is what drives the drug use,” said Yasmin Hurd, the lead researcher on the study and director of the Addiction Institute of Mount Sinai. “If we can have the medications that can dampen that [craving], that can greatly reduce the chance of relapse and overdose risk.” The available medications for opioid addiction, such as buprenorphine and methadone, act in a similar way, curbing cravings. But they are still not widely used. According to the National Institute on Drug Abuse, just one-third of US patients with opioid dependence in private treatment centers actually receive these kinds of medications. According to the 2016 surgeon general’s report on addiction, only 1 in 5 people who needed treatment for opioid use disorders was receiving any sort of therapy. Public health experts say there are obstacles to getting these drugs, which are approved by the US Food and Drug Administration, widely distributed. Because methadone and buprenorphine are still opioids, who can prescribe and how much can be prescribed are highly regulated. In addition, treatment with these medications can require frequent visits with practitioners. “It’s really burdensome,” Hurd said. Concerns about diversion and addiction to these drugs remain, despite their success in reducing mortality by up to 59% a year in the year after treatment.
Thanks for signing up!
Watch for us in your inbox.